CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia

被引:0
|
作者
Sook-Kyoung Heo
Eui-Kyu Noh
Lan Jeong Ju
Jun Young Sung
Yoo Kyung Jeong
Jaekyung Cheon
Su Jin Koh
Young Joo Min
Yunsuk Choi
Jae-Cheol Jo
机构
[1] Ulsan University Hospital,Biomedical Research Center
[2] University of Ulsan College of Medicine,Department of Hematology and Oncology
[3] Ulsan University Hospital,undefined
[4] University of Ulsan College of Medicine,undefined
来源
BMC Cancer | / 20卷
关键词
Acute myeloid leukemia; Leukemic stem cells; CD45; CD34; CD38; CD133; cells; Prognosis; Immunophenotyping;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
    Heo, Sook-Kyoung
    Noh, Eui-Kyu
    Ju, Lan Jeong
    Sung, Jun Young
    Jeong, Yoo Kyung
    Cheon, Jaekyung
    Koh, Su Jin
    Min, Young Joo
    Choi, Yunsuk
    Jo, Jae-Cheol
    BMC CANCER, 2020, 20 (01)
  • [2] Aclinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
    Gerber, Jonathan M.
    Smith, B. Douglas
    Ngwang, Brownhilda
    Zhang, Hao
    Vala, Milada S.
    Morsberger, Laura
    Galkin, Steven
    Collector, Michael I.
    Perkins, Brandy
    Levis, Mark J.
    Griffin, Constance A.
    Sharkis, Saul J.
    Borowitz, Michael J.
    Karp, Judith E.
    Jones, Richard J.
    BLOOD, 2012, 119 (15) : 3571 - 3577
  • [3] CD34+CD38- leukemic stem cell frequency to predict outcome in acute myeloid leukemia
    Zeijlemaker, Wendelien
    Grob, Tim
    Meijer, Rosa
    Hanekamp, Diana
    Kelder, Angele
    Carbaat-Ham, Jannemieke C.
    Oussoren-Brockhoff, Yvonne J. M.
    Snel, Alexander N.
    Veldhuizen, Dennis
    Scholten, Willemijn J.
    Maertens, Johan
    Breems, Dimitri A.
    Pabst, Thomas
    Manz, Markus G.
    van der Velden, Vincent H. J.
    Slomp, Jennichjen
    Preijers, Frank
    Cloos, Jacqueline
    van de Loosdrecht, Arjan A.
    Lowenberg, Bob
    Valk, Peter J. M.
    Jongen-Lavrencic, Mojca
    Ossenkoppele, Gert J.
    Schuurhuis, Gerrit J.
    LEUKEMIA, 2019, 33 (05) : 1102 - 1112
  • [4] CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia
    Wendelien Zeijlemaker
    Tim Grob
    Rosa Meijer
    Diana Hanekamp
    Angèle Kelder
    Jannemieke C. Carbaat-Ham
    Yvonne J. M. Oussoren-Brockhoff
    Alexander N. Snel
    Dennis Veldhuizen
    Willemijn J. Scholten
    Johan Maertens
    Dimitri A. Breems
    Thomas Pabst
    Markus G. Manz
    Vincent H. J. van der Velden
    Jennichjen Slomp
    Frank Preijers
    Jacqueline Cloos
    Arjan A. van de Loosdrecht
    Bob Löwenberg
    Peter J. M. Valk
    Mojca Jongen-Lavrencic
    Gert J. Ossenkoppele
    Gerrit J. Schuurhuis
    Leukemia, 2019, 33 : 1102 - 1112
  • [5] Multicolor Immunophenotyping of Candidate Leukemic Stem Cell Markers in CD34+CD38-Chronic Myeloid Leukemia Stem Cells
    Culen, Martin
    Romzova, Marianna
    Smitalova, Dagmar
    Loja, Tomas
    Mayer, Jiri
    BLOOD, 2019, 134
  • [6] Stem cells in T-ALL have a primitive CD133+/CD34+/CD7-phenotype.
    Cox, CV
    Evely, RS
    Goulden, NJ
    Blair, A
    BLOOD, 2004, 104 (11) : 522A - 522A
  • [7] CD133+ and CD133- Cancer stem cells in glioblastoma
    Beier, D.
    Hau, P.
    Proescholdt, M.
    Lohmeier, A.
    Aigner, L.
    Brawanski, A.
    Bogdahn, U.
    Beier, C. P.
    NEURO-ONCOLOGY, 2006, 8 (04) : 317 - 317
  • [8] The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cells
    Reuvekamp, Tom
    Janssen, Luca L. G.
    Ngai, Lok Lam
    Carbaat-Ham, Jannemieke
    den Hartog, Daphne
    Scholten, Willemijn J.
    Kelder, Angele
    Hanekamp, Diana
    Wensink, Eliza
    van Gils, Noortje
    Gradowska, Patrycja
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    Westers, Theresia M.
    Smit, Linda
    Bachas, Costa
    Cloos, Jacqueline
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2025, 108 (01) : 23 - 34
  • [9] CD34+CD38-Leukemic Stem Cell Load at Diagnosis Predicts Outcome in Acute Myeloid Leukemia
    Hanekamp, D.
    Zeijlemaker, W.
    Kelder, A.
    Ossenkoppele, G. J.
    Schuurhuis, G. J.
    Cloos, J.
    ANNALS OF HEMATOLOGY, 2019, 98 : S23 - S23
  • [10] DIFFERENTIAL NUMBER OF CD34+, CD133+ AND CD34+/CD133+ CELLS IN PERIPHERAL BLOOD OF PATIENTS WITH CONGESTIVE HEART FAILURE
    Fritzenwanger, M.
    Lorenz, F.
    Jung, C.
    Fabris, M.
    Thude, H.
    Barz, D.
    Figulla, H. R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (03) : 113 - 117